🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/03/1998 | 62,89 | 62,92 | 60,65 | 62,02 | -1,42% | 3,60% | 5.052.618 |
| 24/03/1998 | 63,22 | 63,36 | 62,53 | 62,92 | +0,62% | 1,32% | 3.119.058 |
| 23/03/1998 | 62,74 | 63,07 | 61,93 | 62,53 | -0,62% | 1,81% | 4.317.550 |
| 20/03/1998 | 62,65 | 62,95 | 62,08 | 62,92 | +0,67% | 1,38% | 5.452.534 |
| 19/03/1998 | 62,74 | 63,07 | 61,90 | 62,50 | -0,38% | 1,85% | 2.889.965 |
| 18/03/1998 | 62,98 | 63,04 | 62,38 | 62,74 | -0,47% | 1,04% | 3.041.506 |
| 17/03/1998 | 61,81 | 63,16 | 61,67 | 63,04 | +2,03% | 2,41% | 4.448.550 |
| 16/03/1998 | 61,19 | 61,87 | 60,92 | 61,78 | +0,97% | 1,56% | 3.236.224 |
| 13/03/1998 | 62,20 | 62,29 | 60,89 | 61,19 | -0,63% | 2,25% | 3.324.046 |
| 12/03/1998 | 61,55 | 61,84 | 61,01 | 61,58 | -0,53% | 1,36% | 3.240.416 |
| 11/03/1998 | 62,29 | 62,50 | 61,87 | 61,90 | -0,81% | 1,01% | 2.880.533 |
| 10/03/1998 | 61,40 | 62,47 | 61,40 | 62,41 | +1,65% | 1,75% | 4.829.603 |
| 09/03/1998 | 60,89 | 61,52 | 60,71 | 61,40 | +1,03% | 1,32% | 3.894.787 |
| 06/03/1998 | 59,34 | 61,13 | 59,34 | 60,77 | +2,98% | 3,02% | 4.049.682 |
| 05/03/1998 | 59,28 | 60,29 | 59,01 | 59,01 | -0,95% | 2,16% | 5.268.086 |
| 04/03/1998 | 60,03 | 60,20 | 59,43 | 59,58 | -1,53% | 1,29% | 3.748.067 |
| 03/03/1998 | 60,44 | 61,19 | 60,26 | 60,50 | +0,00% | 1,53% | 3.537.629 |
| 02/03/1998 | 60,86 | 61,13 | 60,35 | 60,50 | -0,59% | 1,27% | 3.398.245 |
| 27/02/1998 | 60,29 | 61,01 | 60,23 | 60,86 | +1,24% | 1,29% | 4.257.605 |
| 26/02/1998 | 60,65 | 61,13 | 59,73 | 60,11 | -0,69% | 2,31% | 4.350.667 |
| 25/02/1998 | 61,49 | 61,49 | 60,26 | 60,53 | -0,83% | 1,99% | 5.640.336 |
| 24/02/1998 | 61,58 | 62,02 | 60,83 | 61,04 | -2,06% | 1,94% | 7.039.626 |
| 23/02/1998 | 60,23 | 62,44 | 60,23 | 62,32 | +4,76% | 3,66% | 10.153.024 |
| 20/02/1998 | 58,41 | 59,61 | 57,82 | 59,49 | +1,99% | 3,06% | 6.607.221 |
| 19/02/1998 | 58,62 | 58,98 | 58,24 | 58,33 | -1,61% | 1,27% | 4.737.589 |
| 18/02/1998 | 57,31 | 59,28 | 57,07 | 59,28 | +3,65% | 3,85% | 8.216.320 |
| 17/02/1998 | 56,45 | 57,64 | 56,30 | 57,19 | +1,86% | 2,38% | 7.864.192 |
| 13/02/1998 | 55,76 | 56,24 | 55,58 | 56,15 | -0,11% | 1,18% | 3.363.451 |
| 12/02/1998 | 56,06 | 56,51 | 55,22 | 56,21 | +0,27% | 2,29% | 4.770.286 |
| 11/02/1998 | 56,30 | 56,30 | 55,43 | 56,06 | +0,05% | 1,54% | 4.496.968 |